Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Inc. buy Morgan Stanley

Start price
€63.10
06.05.26 / 50%
Target price
-
06.05.27
Performance (%)
5.17%
Price
€66.36
07.08.26
Summary
This prediction is currently active. With a performance of 5.17%, the BUY prediction by Morgan_Stanley for Cytokinetics Inc. is trending in the right direction. This prediction currently runs until 06.05.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Cytokinetics Inc. -0.778% -0.778%
iShares Core DAX® 2,57 % 5,33 %
iShares Nasdaq 100 4,86 % 0,45 %
iShares Nikkei 225® 5,59 % -0,59 %
iShares S&P 500 3,25 % 2,50 %

Comments by Morgan_Stanley for this prediction

In the thread Discuss Cytokinetics Inc.

Cytokinetics (CYTK) had its "overweight" rating reaffirmed by Morgan Stanley.
Ratings data for CYTK provided by MarketBeat

Stopped prediction by Morgan_Stanley for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€56.00
22.12.25
-
22.12.26
18.50%
07.08.26

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€41.00
13.02.25
€64.45
13.02.26
35.37%
14.02.26

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€30.20
04.08.23
€54.39
04.08.24
67.22%
05.08.24